MED vs LAD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 02, 2026

MED

46.5
AI Score
VS
LAD Wins

LAD

59.7
AI Score

Investment Advisor Scores

MED

47score
Recommendation
HOLD

LAD

60score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MED LAD Winner
Revenue 76.04M 19.06B LAD
Net Income -2.12M 360.40M LAD
Gross Margin 68.1% 15.3% MED
Net Margin -2.8% 1.9% LAD
Operating Income -3.29M 784.10M LAD
ROE -1.1% 5.6% LAD
ROA -0.8% 1.4% LAD
Total Assets 252.05M 26.25B LAD
Cash 71.53M 110.30M LAD
Current Ratio 4.80 1.00 MED
Free Cash Flow -836,000 -327.50M MED

Relative Price Performance (Last 90 Days)

MED 1M: -10.9% · 3M: -9.6% LAD 1M: +32.8% · 3M: +32.8%

Current Technical Phase

MED

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.2%), weak momentum, RSI 40

RSI (14): 39.8 · Price: $9.83

LAD

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (8.3% over 20 days), RSI 65

RSI (14): 64.9 · Price: $385.42

Fundamentals Snapshot

Metric MED LAD
Market Cap
Forward P/E -16.5 9.2
Trailing P/E 14.9
Revenue (TTM)
Revenue Growth -0.3% 0.0%
Gross Margin 0.7% 0.2%
Operating Margin -0.1% 0.0%
EPS -1.82 27.14
Dividend Yield 0.00%

Frequently Asked Questions

Based on our detailed analysis, LAD is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.